Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06851598
PHASE2/PHASE3

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

Sponsor: Abdallah Mohamed Abdallah Mohamed Elgendy

View on ClinicalTrials.gov

Summary

The aim of this work is to assess the efficacy and safety of Botulinum toxin - A injection into ischiocavernosus muscle in treatment of primary premature ejaculation.

Official title: Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle in Treatment of Premature Ejaculation

Key Details

Gender

MALE

Age Range

16 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-07-01

Completion Date

2025-03-01

Last Updated

2025-02-28

Healthy Volunteers

No

Interventions

DRUG

25 units botox

25 units of botox injection into ischiocavernosus muscle

DRUG

50 units Botox

50 Units botox injection into ischiocavernosus muscle

DRUG

75 units Botox

75 units botox injection into ischiocavernosus muscle

Locations (1)

Faculty of Medicine, Al-Azhar University

Cairo, Egypt